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ABSTRACT 
 
 Organophosphates are a class of toxicants that act by inhibiting the activity of 
acetylcholinesterase, an enzyme vital to normal neuronal activity. Dimethoate and omethoate are 
two organophosphates that are chemical “cousins” of one another. Omethoate is a metabolite, 
or byproduct of dimethoate decomposition, and is more toxicologically active than dimethoate. 
Both toxicants were applied to cultures of Caenorhabditis elegans to determine two qualities of 
the organophosphates: their relative toxicity and their cumulative effects. The toxicity of 
omethoate was found to be significantly higher than that of dimethoate. Omethoate was found 
to have a 144.4% more lethal toxicity than dimethoate, and was 132.3% more effective at causing 
flaccid paralysis. Neither compound exhibited notable cumulative effects.  
Keywords: organophosphate, neurotoxicity, omethoate, dimethoate, toxicity, 
acetylcholinesterase 
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INTRODUCTION 
 The purpose of this study was to determine the toxicity and potency of dimethoate, and 
its metabolite, omethoate on neurotoxicity. These compounds belong to a class of insecticides 
called organophosphates, which, until they were banned in 2001, were administered to 
agricultural fields. Organophosphates were used in the development of chemical weapons in the 
1940’s. These concoctions, called nerve agents, had various codenames and were used to 
incapacitate and potentially kill large groups of targets at once (Gilbert, 2014). Cholinesterase 
inhibition activity is the method by which organophosphates are toxic.  
A value for LC50 and EC50 must be determined to quantify and express data collected 
related to the toxicity of each organophosphate. An LC50 (Lethal Concentration 50) is the value 
of the dosage that will kill 50% of the sample population if administered. EC50 (Effective 
Concentration 50) is similar, but represents an endpoint other than death; for example, if the 
substance being tested is a pharmaceutical, the EC50 is the dosage that elicits the desired effect 
in 50% of test subjects. To determine these benchmarks, an endpoint must be established. 
According to previous toxicological research of Caenorhabditis elegans (C. elegans), the most 
useful endpoint is impairment of motility. The hypothesis of this study has two parts. Firstly that 
omethoate, being more active than dimethoate, will have a greater effect than dimethoate at a 
similar concentration. The second hypothesis regarding cumulative effects is that neither 
organophosphate will display a notable ability to accumulate inside of an organism because of 
the rate at which they decompose. Data gained from this experiment was used to estimate the 
toxicity of both compounds to humans, based on toxicological data relating C. elegans to Homo 
sapiens.  
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C. elegans is a roundworm that is about 1 mm in length which can be found in soil. In 
terms of value in toxicology, Leung states in Caenorhabditis elegans: An Emerging Model in 
Biomedical and Environmental Toxicology, written in 2008, that C. elegans is a prime organism 
for studying eukaryotic toxicology, especially in terms of neurotoxicity. Leung mentions that C. 
elegans is useful in studying several fields of neurotoxicity: metal toxicity, neurodegeneration 
caused by a toxicant, and, most importantly for our study, the effects of toxic pesticides. This 
study compares the toxicity of two pesticides, dimethoate and omethoate. These pesticides 
belong to a class of toxicants called organophosphates.  
C. elegans is a suitable choice for a model organism for this study for two main reasons. 
First, it is easy to culture and grow. This roundworm can thrive at room temperature 
(recommended temperature is about 20oC) as long as it has access to oxygen and food, which 
comes in the form of Escherichia coli bacteria applied directly to the culture plates of C. elegans. 
The second reason C. elegans is a desirable model organism for this study is the level of detail 
that is known about its nervous system, along with the fact that its nervous system is similar to 
that of a human’s. For example, it is known that each organism has 302 neurons (Hobert, 2005). 
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REVIEW OF LITERATURE 
C. elegans, being a living organism, requires some basic needs to be met in order to 
survive long enough to be of experimental use. First of all, a food source is required. This is 
achieved by introducing C. elegans to bacterial culture media which has been cultured with E. 
coli, a food source for C. elegans. It is important to prevent the organism from starvation, as this 
can impact toxicological findings (Boyd, 2003). 
There are 959 cells in female organisms, and 1031 in male organisms. The growth 
patterns exhibited by these cells are generally uniform from organism to organism. C. elegans 
takes four days to go from egg to a mature, fertile adult. The organism has a lifespan of two to 
three weeks. These times are based on a constant environmental temperature of 20oC (Felix, 
2010). While most of the worms are hermaphroditic females, meaning that they can reproduce 
asexually, a few worms are male. If a worm self-fertilizes, it can produce up to 300 eggs. If the 
worm is fertilized by a male, the egg count more than triples to a possible 1000 eggs. It is 
important to understand the life cycle of this organism in order to reduce variability in testing 
and data collection. 
When working in a lab setting, safety is always a concern. A focus on safety is even more 
critical when working with highly potent toxins like dimethoate and omethoate. For this reason, 
it is important to understand how these substances are to be safely handled and disposed of. 
Organophosphates such as dimethoate and its metabolite, omethoate, absorb easily into 
tissues. Because of this, protection such as gloves, goggles, and masks are recommended when 
dealing with them, especially in doses high enough to negatively impact humans. Dimethoate is 
a solid at room temperature, while omethoate is liquid, and both must be refrigerated to be 
kept stable. Both decompose quickly in soil and when exposed to direct sunlight for a prolonged 
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period of time. (Cornell, 1993) Dimethoate decomposes especially rapidly when exposed to high 
heat, and is subject to explosion. Finally, both compounds are most safely disposed of using 
“quick lime”, and should not be drained into public water systems. (Kilford, 2014)  
The predicted oral LD50 for dimethoate in humans is 30mg/kg (Uchida, 1996). No 
substantial data exists concerning omethoate; the only fatal exposure case on record was a 
suicide involving omethoate insecticides. However, in the 1991 article Human toxicology of 
pesticides, Simeonova found that the acceptable daily intake of omethoate is .0003 ppm. 
Previous studies suggest that LC50 values are expected to fall in the range of about 1.00 to 100. 
ppm (Cole). Our experimental range greatly exceeds this amount, but not all of the administered 
solution will make it into a single roundworm, instead it is shared by all the worms in the dish. 
Also, part of this study involves determining the acute toxicity of both compounds, which 
implies that the administered concentration should be higher than that of an “acceptable daily 
intake.” 
Organophosphates have distinct toxicological effects. They have been shown to 
negatively affect reproduction in adult organisms (mice), as well as the survival of offspring. 
These effects are observed in exposure to both compounds, but the potency of omethoate is 
higher than that of dimethoate. This means less omethoate is required to produce the same 
effects as a higher concentration of dimethoate. Cole found the EC50 of omethoate (4.47 mM) 
to be 9.44% of the EC50 of dimethoate (42.2 mM) (p. 250). 
Organophosphates are toxic through all routes of exposure. They are most easily 
absorbed in lungs, but also pass through the epidermis and digestive tract. (McVey, p. 4) 
Symptoms may manifest some time (1-4 weeks in humans) after an acute exposure event. 
Chronic exposure results in the same symptoms of acute exposure. Dimethoate has also been 
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shown to have teratogenic, and mutagenic effects in mammals. Carcinogenic effects have been 
observed in some studies. Common symptoms of dimethoate overexposure are weakness, 
involuntary muscle spasms and loss of appetite. (Cornell, 1993) The root of the most common 
symptoms is the inhibition of cholinesterase in the synaptic cleft, resulting in nervous 
dysfunction.  
Organophosphates are cholinesterase inhibitors. They prevent the enzyme 
cholinesterase from decomposing acetylcholine, an important neurotransmitter. This results in 
accumulation of acetylcholine in the synaptic cleft, causing the receptors that are specific for the 
ligand to be overstimulated. (Pope, p. 433) This overstimulation can cause permanent damage 
to a victim, especially a developing fetus. A study done by the Food and Agriculture Organization 
of the United Nations found that when rats were exposed to various levels of dimethoate by 
oral, dermal, or intravenous exposure, 0.2% to 3.7% of the initial dimethoate dose was 
metabolized into omethoate. The metabolite found in abundance was dimethyl hydrogen 
phosphorodithioate, a harmless waste product. (No, p. 385) This suggests that most of the 
dimethoate was transformed inside the body to be excreted. 
All good toxicity studies have at least one endpoint besides death. A common endpoint, besides 
death, in studies involving C. elegans is impairment of motility (Anderson, 2003). The 
neurological effects of the organophosphate family often result in loss of movement in 
C.Elegans (Rajini, 2008). As more acetylcholine binds to neurotransmitters, the rate of muscle 
contraction increases. Opperman found that nematodes experienced a short burst of 
hyperactivity (likely because of the increased concentration of acetylcholine) followed by rigid, 
then flaccid paralysis (likely due to overstimulation of the nervous system). This finding was 
published in 1990 in Plant-parasitic Nematode Acetylcholinesterase Inhibition by Carbamate and 
Organophosphate Nematicides. Previous studies used an image based computer tracking system 
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to express changes in movement as a percent of movement of the control (Cole, 2003; Rajini, 
2008). Lacking this sophisticated equipment requires the use of an alternative method of 
quantifying motility. C. elegans move in a unique manner. Instead of a smooth continuous 
movement, like that of a snake, they move in short “pulses.” In order to quantify the motility of 
the nematode, the number of pulses made in a set amount of time is a suitable substitute.  
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MATERIALS AND METHODS 
To achieve a large enough population of C. elegans to perform an experiment on, 
subcultures were made on 35mm diameter Petri dishes containing Nematode Growth Agar 
(NGA, purchased from Carolina Scientific). The agar was inoculated with an LB broth solution 
containing a strain of OP50 E. coli (purchased from Carolina Scientific), which served as a food 
source for the nematodes. Strain N2 C. elegans were transferred from the original plate 
(purchased from Carolina Scientific) by cutting the agar in the original plate into 1 cm by 1 cm 
squares, and then transferring these squares onto the plate designated for subculture. The 
squares of NGA containing live C. elegans must be applied face down to the new agar to ensure 
that the organisms come into direct contact with their new medium. The subculture plates were 
then wrapped in Parafilm M and stored at 20oC for three days to allow any new eggs to hatch on 
the new medium. Parafilm M is permeable to oxygen and has no effect on the growth and 
development of C. elegans. (Rothman, p.75; Spica) Subcultures reserved for maintaining a viable 
population were kept for up to 10 days before a new subculture was made. Subcultures 
reserved for experimentation were only allowed to sit for three days after inoculation with C. 
elegans to ensure a young healthy population, as well as to reduce variability.  
Solutions of organophosphate and water were prepared by making a stock solution of 
100,000 ppm by adding 10mg of organophosphate per 1 mL of water. The various solutions used 
during experimentation were prepared from dilutions of this stock solution. When not in use, all 
solutions containing organophosphate were kept inside of a freezer to prevent the 
decomposition of the organophosphates. At the end of the experiment, the solutions were 
mixed with excess amounts of ”quick lime” to neutralize the toxicants.  
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This experiment consisted of two different trials. The first trial was an acute exposure 
trial, while the second was an extended, chronic exposure trial. The first trial involved working 
with higher concentrations of organophosphate, but only one exposure event. The second trial 
used significantly lower concentrations, but had multiple exposure events spread over a longer 
period of time. 
To quantify movement, worms were observed on an individual basis for 20 seconds 
each. The nature of C. elegans movement causes them to move in short “pulses” instead of 
smooth movement. These pulses were counted during the 20 second duration and subsequently 
recorded in a data table. A sample size of 25 worms was used to achieve an average number of 
pulses per worm in each plate. This method of quantifying movement was used in both the 
acute and chronic toxicity trials. Worms exhibiting either rigid or flaccid paralysis were counted 
as “paralyzed.” Rigid paralysis is best described as a straightening of the worms’ usual wavy 
shape, with occasional twitches. Flaccid paralysis is characterized by a relaxation of the worms. 
At this point, their nervous systems “short circuit” from the overstimulation of acetylcholine 
that occurred during the rigid paralysis phase. Paralyzed worms are easy to differentiate from 
dead worms, as the dead C. elegans curl up upon passing.  
The first trial began with two sets of five cultures (one set for each toxicant) and a 
control. Toxicants were administered in a dropwise manner at a volume of .5 ml, spread across 
the face of the medium. The concentrations used for both organophosphates were 50ppm, 
100ppm, 500ppm, 1000ppm, and 5000ppm. Each plate was observed immediately after 
exposure, and the motility of the C. elegans inside was recorded. The motility of the nematodes 
was also observed 30 minutes after the initial exposure event. This data was translated into a 
probit plot to determine the LC50 and EC50 of each toxicant. The probit plot compares the 
proportion of the sample that elicits a positive response (death or loss of motility) to the 
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concentration of organophosphate used, represented on a probit-log scale. A probit transform is 
a way to represent sigmoid curve data in a linear fashion, making it easier to interpret. 
The second trial began in the same manner as the acute toxicity trial, with two sets of 
five cultures, plus one culture to serve as a control. The concentrations used in this trial were 
5ppm, 10ppm, 50ppm, 100ppm, and 500ppm. These concentrations were chosen based on the 
results of the first trial. This trial was carried out over the course of seven days, with a fresh dose 
of organophosphate in the amount of .5ml administered every 12 hours at the same time every 
day. Before each exposure event besides the first one, the nematodes were observed, and their 
motility levels recorded in the matter described above. The same area was observed each time, 
so that if any organisms died during the trial, they would always be counted, as they would stay 
in the designated area. The collected data was compiled into a probit plot, and LC50 and EC50 
values were determined. 
In the interest of accuracy, each trial was run in duplicate. The results of each run of 
each trial are represented separately on all figures. The acute toxicity trial was actually run three 
times, but the first run involved concentrations of organophosphate that were too low to 
achieve a lethal concentration. The concentrations used in the acute exposure trial were raised 
by an order of magnitude, and the trial was run two more times under the revised conditions. 
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RESULTS 
Table 1 below lists the LC50 and EC50 values for each organophosphate calculated from 
each run of the acute toxicity trial. This table compares the averages of both values for each 
toxicant as a percentage. 
Table 1: Comparison of LC50 and EC50 Values 
Dimethoate Omethoate 
LC50 LC50 
Run #1 
121.2 ppm 
Run #2 
119.6 ppm 
Run #1 
96.5 ppm 
Run #2 
70.8 ppm 
Average LC50 
120.4 ppm 
Average LC50 
83.4 ppm 
 (144.4% more effective than dimethoate) 
EC50 EC50 
Run #1 
29.9 ppm 
Run #2 
30.6 ppm 
Run #1 
19.4 ppm 
Run #2 
26.3 ppm 
Average EC50 
30.3 ppm 
Average EC50 
22.9 ppm 
(132.3% more effective than dimethoate) 
 
 The following figures (Figures 1-4) display the probit plots obtained from run #1 of the 
acute toxicity trial. Tables 2-5 contain the raw data that went into Figures 1-4. 
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 Figure 1: Probit analysis of lethal 
omethoate toxicity for run #1 of acute 
toxicity trial. 
 
 
Figure 2: Probit analysis of effective 
omethoate toxicity for run #1 of 
acute toxicity trial. 
 
 
 
 
Table 2:  Raw data of lethal 
omethoate toxicity for run #1 of 
acute toxicity trial. 
Dosage Number 
dead 
probit 
units 
0 0 0 
10 3 3.96357 
50 7 4.61468 
100 10 5 
500 15 5.67449 
1000 18 6.28155 
Table 3: Raw data of effective 
omethoate toxicity for run #1 of 
acute toxicity trial. 
Dosage Number 
paralyzed 
probit 
units 
0 0 0 
10 10 5 
50 13 5.38532 
100 15 5.67449 
500 17 6.036433 
1000 19.99 8.290527 
y = 0.4881ln(x) + 2.7698
R² = 0.986
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Figure 3: Probit analysis of lethal 
dimethoate toxicity for run #1 of acute 
toxicity trial. 
 
 
Figure 4: Probit analysis of effective 
dimethoate toxicity for run #1 of acute 
toxicity trial. 
  
Table 4: Raw data of lethal 
dimethoate toxicity for run #1 of 
acute toxicity trial. 
Dosage Number dead probit 
units 
0 0 0 
10 2 3.718448 
50 5 4.32551 
100 11 5.125661 
500 14 5.524401 
1000 18 6.281552 
Table 5: Raw data of effective 
dimethoate toxicity for run #1 of 
acute toxicity trial. 
Dosage Number 
Paralyzed 
probit 
units 
0 0 0 
10 8 4.746653 
50 11 5.125661 
100 13 5.38532 
500 17 6.036433 
1000 19.99 8.290527 
y = 0.5344ln(x) + 2.4362
R² = 0.957
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its
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 The following figures (Figures 5-8) and their accompanying tables (Tables 6-9) represent 
data collected from run #2 of the acute toxicity trial. 
Figure 5: Probit analysis of lethal 
omethoate toxicity for run #2 of 
acute toxicity trial. 
 
Figure 6: Probit analysis of effective 
omethoate toxicity for run #2 of 
acute toxicity trial. 
 
 
 
Table 6: Raw data of lethal 
omethoate toxicity for run #2 
of acute toxicity trial. 
Dosage Number 
dead 
probit 
units 
0 0 0 
10 4 4.158379 
50 7 4.61468 
100 11 5.125661 
500 16 5.841621 
1000 19 6.644854 
Table 7: Raw data of effective 
omethoate toxicity for run #2 
of acute toxicity trial. 
Dosage Number 
Paralyzed 
probit 
units 
0 0 0 
10 9 4.874339 
50 11 5.125661 
100 14 5.524401 
500 16 5.841621 
1000 20 8.290527 
y = 0.5252ln(x) + 2.7624
R² = 0.9545
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Figure 7: Probit analysis of lethal 
dimethoate toxicity for run #2 of 
acute toxicity trial. 
 
 
Figure 8: Probit analysis of 
effective dimethoate toxicity for 
run #2 of acute toxicity trial. 
 
 
  
Table 8: Raw data of lethal 
dimethoate toxicity for run #2 of 
acute toxicity trial. 
Dosage Number 
dead 
probit 
units 
0 0 0 
10 2 3.718448 
50 6 4.475599 
100 12 5.253347 
500 14 5.524400 
1000 17 6.036433 
Table 9: Raw data of effective 
dimethoate toxicity for run #2 
of acute toxicity trial. 
Dosage Number 
Paralyzed 
probit 
units 
0 0 0 
10 8 4.746653 
50 10 5 
100 14 5.524401 
500 16 5.841621 
1000 20 8.290527 
y = 0.4845ln(x) + 2.6819
R² = 0.9517
2.8
3.8
4.8
5.8
6.8
7.8
1 10 100 1000
Pr
ob
it 
un
its
Dosage (ppm)
Dimethoate Acute Toxicity Run #2 
(LC50)
y = 0.6447ln(x) + 2.7936
R² = 0.702
2.8
3.8
4.8
5.8
6.8
7.8
8.8
9.8
1 10 100 1000
Pr
ob
it 
un
its
Dosage (ppm)
Dimethoate Acute Toxicity Run #2 
(EC50)
15 
 
Figures 9-12 represent data taken from the chronic toxicity study. 
 
Figure 9: Graphical representation of Table 10. Dose of omethoate versus number of dead C. 
elegans over 7 days at 12 hour increments. 
 
Figure 10: Bar graph comparing total number of dead C. elegans on day 7 of the omethoate 
chronic toxicity trial. 
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Figure 11: Graphical representation of Table 11. Dose of dimethoate versus number of dead C. 
elegans over 7 days at 12 hour increments. 
 
Figure 12: Bar graph comparing total number of dead C. elegans on day 7 of the dimethoate 
chronic toxicity trial. 
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DISCUSSION 
The first hypothesis in this study states that omethoate is more active, and thus more 
potent than dimethoate. This hypothesis is supported based on the data collected in the acute 
toxicity trial. As seen in Table 1, the average LD50 of omethoate (83.4ppm) was 69.3% of the 
average LD50 for dimethoate (120.4ppm), which means that omethoate was 144.4% more 
effective at killing C. elegans than dimethoate. The average EC50 of omethoate (22.9ppm) was 
75.6% of the average EC50 of dimethoate (30.3ppm), translating to a 132.3% increase in 
effectiveness over dimethoate. Qualitatively, this data is supported by findings made by Cole. 
Cole found that the EC50 of omethoate was a mere 9.44% of the EC50 of dimethoate (p. 250). 
While Cole’s data supports our hypothesis of omethoate having a higher potency than 
dimethoate, it also suggests that the difference in potencies of the two organophophates in this 
study is very low. This could arise from cross contamination of the organophosphate solutions or 
another form of experimental error. Figures 1-8 and their associated tables (Tables 2-9) present 
probit plots that do not exhibit sharp peaks, which would indicate that the test plates were not 
exposed to the same conditions. Cole’s study also suggests that LC50 values should fall between 
1.00 and 100 ppm. The LD50 values found in this study are close to this range, and lean towards 
the upper end of the spectrum. 
The second hypothesis states that neither organophosphate will display any definite 
ability to accumulate inside the organism. Figure 9 and 10 show that while plates exposed to a 
higher concentration of omethoate showed a higher amount of dead worms, this increase is 
only slight. The increase is small enough to suggest that omethoate has an insignificant amount 
of accumulation ability. Figures 11 and 12 suggest that the same is true for dimethoate as well. 
Keenland states that organophosphates rarely show bioaccumulation activity, supporting this 
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hypothesis further. Although organophosphates irreversibly inhibit acetylcholinesterase, new 
enzyme is produced to counter the effects of the toxicant. (Doctor, p. 168)   
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APPENDIX 
Appendix 1: Data tables 
Both of the below tables contain data collected from the chronic toxicity study. 
 
 
Dose of dimethoate versus number of dead C. elegans over 7 days at 12 hour increments 
Dose 
(ppm) 
.5 
day 
1 
day 
1.5 
days 
2 
days 
2.5 
days 
3 
days 
3.5 
days 
4 
days 
4.5 
days 
5 
days 
5.5 
days 
6 
days 
6.5 
days 
7 
days 
0 0 0 0 0 0 0 1 1 1 3 3 3 4 6 
5 0 0 0 0 0 0 1 1 1 2 2 4 4 5 
10 0 0 0 0 0 0 1 1 2 2 2 4 4 5 
50 0 0 0 0 0 1 1 1 1 3 4 5 5 6 
100 0 0 0 0 0 1 1 3 3 3 4 5 6 6 
500 0 0 0 0 0 2 2 2 2 4 4 5 7 7 
 
 
 
Dose of omethoate versus number of dead C. elegans over 7 days at 12 hour increments 
Dose 
(ppm) 
.5 
day 
1 
day 
1.5 
days 
2 
days 
2.5 
days 
3 
days 
3.5 
days 
4 
days 
4.5 
days 
5 
days 
5.5 
days 
6 
days 
6.5 
days 
7 
days 
0 0 0 0 0 0 0 1 1 1 2 3 4 5 5 
5 0 0 0 0 0 0 1 1 1 2 2 4 5 5 
10 0 0 0 0 0 1 1 1 2 2 2 4 4 6 
50 0 0 0 0 0 0 1 1 2 2 4 4 5 5 
100 0 0 0 0 0 1 1 2 2 3 4 4 6 6 
500 0 0 0 0 1 1 1 2 2 4 4 6 7 7 
